Xpogen Licenses PathlinX Software to Johns Hopkins | GenomeWeb

NEW YORK, May 8 - Bioinformatics company Xpogen today said it has licensed its PathlinX 3.0 gene expression-analysis software to Johns Hopkins Medical Center.

According to Cambridge, Mass.-based Xpogen, the PathlinX software was designed to identify differentially co-expressed genes in two-state method-of-action experiments.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.